approval
saveSPEVIGO (SPESOLIMAB-SBZO) — FDA approval
community read0 votes
Sponsor: BOEHRINGER INGELHEIM PHARMACEUTICALS INC. Form: INJECTABLE. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
same company · ±60 days · 6
- approvalCYLTEZO: CYLTEZO (ADALIMUMAB-ADBM) — FDA approvalOct 3, 2022
- approvalSYNJARDY: JARDIANCE (EMPAGLIFLOZIN) — FDA approvalOct 13, 2022
- approval(empagliflozin + metformin hydrochloride ER): SYNJARDY XR (EMPAGLIFLOZIN) — FDA approvalOct 13, 2022
- approval(empagliflozin + linagliptin + metformin hydrochloride) ER: TRIJARDY XR (EMPAGLIFLOZIN) — FDA approvalOct 13, 2022
- approval(empagliflozin + linagliptin): GLYXAMBI (EMPAGLIFLOZIN) — FDA approvalOct 13, 2022
- approvalSYNJARDY: SYNJARDY (EMPAGLIFLOZIN) — FDA approvalOct 13, 2022
comments(0)
5-min edit window · permanent after that